Home/Filings/4/0001104659-22-057537
4//SEC Filing

Leider Harry L. 4

Accession 0001104659-22-057537

CIK 0001805087other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:17 PM ET

Size

11.1 KB

Accession

0001104659-22-057537

Insider Transaction Report

Form 4
Period: 2022-05-06
Leider Harry L.
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-05-06+269,660314,090 total
  • Award

    Stock Option (Right to Buy)

    2022-05-06+269,660269,660 total
    Exercise: $3.33Exp: 2032-03-03Common Stock (269,660 underlying)
  • Award

    Common Stock

    2022-05-06+34,26644,430 total
  • Award

    Common Stock

    2022-05-06+10,16410,164 total
Footnotes (5)
  • [F1]Represents a grant of restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement.
  • [F2]These RSUs vest in full on February 8, 2023, subject to the reporting person's continued service at such time.
  • [F3]These RSUs vest in full on February 15, 2023, subject to the reporting person's continued service at such time.
  • [F4]25% of these RSUs shall vest on April 1, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.
  • [F5]25% of the shares underlying this option shall vest and become exercisable on March 4, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.

Issuer

GELESIS HOLDINGS, INC.

CIK 0001805087

Entity typeother

Related Parties

1
  • filerCIK 0001888273

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:17 PM ET
Size
11.1 KB